Literature DB >> 26975712

Adrenal Venous Sampling in Patients With Positive Screening but Negative Confirmatory Testing for Primary Aldosteronism.

Hironobu Umakoshi1, Mitsuhide Naruse2, Norio Wada1, Takamasa Ichijo1, Kohei Kamemura1, Yuichi Matsuda1, Yuichi Fujii1, Tatsuya Kai1, Tomikazu Fukuoka1, Ryuichi Sakamoto1, Atsushi Ogo1, Tomoko Suzuki1, Kazutaka Nanba1, Mika Tsuiki1.   

Abstract

Adrenal venous sampling is considered to be the most reliable diagnostic procedure to lateralize aldosterone excess in primary aldosteronism (PA). However, normative criteria have not been established partially because of a lack of data in non-PA hypertensive patients. The aim of the study was to investigate aldosterone concentration and its gradient in the adrenal vein of non-PA hypertensive patients. We retrospectively studied the results of cosyntropin-stimulated adrenal venous sampling in 40 hypertensive patients who showed positive screening testing but negative results in 2 confirmatory tests/captopril challenge test and saline infusion test. Plasma aldosterone concentration, aldosterone/cortisol ratio, its higher/lower ratio (lateralization index) in the adrenal vein with cosyntropin stimulation were measured. Median plasma aldosterone concentration in the adrenal vein was 25 819 pg/mL (range, 5154-69 920) in the higher side and 12 953 (range, 1866-36 190) pg/mL in the lower side (P<0.001). There was a significant gradient in aldosterone/cortisol ratio between the higher and the lower sides (27.2 [5.4-66.0] versus 17.3 [4.0-59.0] pg/mL per μg/dL;P<0.001) with lateralization index ranging from 1.01 to 3.87. The aldosterone lateralization gradient was between 1 to 2 in 32 patients and 2 to 4 in 8 patients. None of the patients showed lateralization index ≥4. The present study demonstrated that plasma aldosterone concentration in the adrenal veins showed significant variation and lateralization gradient even in non-PA hypertensive patients. Adrenal venous sampling aldosterone lateralization gradients between 2 and 4 should be interpreted with caution in patients with PA because these gradients can be found even in patients with negative confirmatory testing for PA.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  aldosterone; hyperaldosteronism; hypertension; primary hyperaldosteronism

Mesh:

Substances:

Year:  2016        PMID: 26975712     DOI: 10.1161/HYPERTENSIONAHA.115.06607

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  10 in total

1.  Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan.

Authors:  Yuichi Fujii; Yoshiyu Takeda; Isao Kurihara; Hiroshi Itoh; Takuyuki Katabami; Takamasa Ichijo; Norio Wada; Yui Shibayama; Takanobu Yoshimoto; Yoshihiro Ogawa; Junji Kawashima; Masakatsu Sone; Nobuya Inagaki; Katsutoshi Takahashi; Minemori Watanabe; Yuichi Matsuda; Hiroki Kobayashi; Hirotaka Shibata; Kohei Kamemura; Michio Otsuki; Koichi Yamamto; Atsushi Ogo; Toshihiko Yanase; Shintaro Okamura; Shozo Miyauchi; Megumi Fujita; Tomoko Suzuki; Hironobu Umakoshi; Tatsuki Ogasawara; Mika Tsuiki; Mitsuhide Naruse
Journal:  J Hum Hypertens       Date:  2019-08-28       Impact factor: 3.012

2.  Subtype prediction of primary aldosteronism by combining aldosterone concentrations in the left adrenal vein and inferior vena cava: a multicenter collaborative study on adrenal venous sampling.

Authors:  Yuichi Fujii; Hironobu Umakoshi; Norio Wada; Takamasa Ichijo; Kohei Kamemura; Yuichi Matsuda; Tatsuya Kai; Tomikazu Fukuoka; Ryuichi Sakamoto; Atsushi Ogo; Tomoko Suzuki; Kazutaka Nanba; Mika Tsuiki; Mitsuhide Naruse
Journal:  J Hum Hypertens       Date:  2017-11-24       Impact factor: 3.012

3.  Performance of Confirmatory Tests for Diagnosing Primary Aldosteronism: a Systematic Review and Meta-Analysis.

Authors:  Alexander A Leung; Christopher J Symonds; Gregory L Hundemer; Paul E Ronksley; Diane L Lorenzetti; Janice L Pasieka; Adrian Harvey; Gregory A Kline
Journal:  Hypertension       Date:  2022-06-02       Impact factor: 9.897

Review 4.  Diagnosing and Managing Primary Aldosteronism in Hypertensive Patients: a Case-Based Approach.

Authors:  Robert M Carey
Journal:  Curr Cardiol Rep       Date:  2016-10       Impact factor: 2.931

5.  Primary aldosteronism: from case detection to histopathology with up to 6 years of follow-up.

Authors:  Gudbjörg Jonsdottir; Jon Gudmundsson; Gudjon Birgisson; Helga Agusta Sigurjonsdottir
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-11-23       Impact factor: 3.738

Review 6.  New Advances in the Diagnostic Workup of Primary Aldosteronism.

Authors:  Martin J Wolley; Michael Stowasser
Journal:  J Endocr Soc       Date:  2017-01-27

Review 7.  Subtype Diagnosis of Primary Aldosteronism: Is Adrenal Vein Sampling Always Necessary?

Authors:  Fabrizio Buffolo; Silvia Monticone; Tracy A Williams; Denis Rossato; Jacopo Burrello; Martina Tetti; Franco Veglio; Paolo Mulatero
Journal:  Int J Mol Sci       Date:  2017-04-17       Impact factor: 5.923

8.  Adrenal Venous Sampling for Subtype Diagnosis of Primary Hyperaldosteronism.

Authors:  Mitsuhide Naruse; Akiyo Tanabe; Koichi Yamamoto; Hiromi Rakugi; Mitsuhiro Kometani; Takashi Yoneda; Hiroki Kobayashi; Masanori Abe; Youichi Ohno; Nobuya Inagaki; Shoichiro Izawa; Masakatsu Sone
Journal:  Endocrinol Metab (Seoul)       Date:  2021-10-21

9.  Approach to the Patient with Primary Aldosteronism: Utility and Limitations of Adrenal Vein Sampling.

Authors:  Adina F Turcu; Richard Auchus
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

10.  Correlation Between Lateralization Index of Adrenal Venous Sampling and Standardized Outcome in Primary Aldosteronism.

Authors:  Hironobu Umakoshi; Mika Tsuiki; Maki Yokomoto-Umakoshi; Yoshiyu Takeda; Yoneda Takashi; Isao Kurihara; Hiroshi Itoh; Takuyuki Katabami; Takamasa Ichijo; Norio Wada; Yui Shibayama; Takanobu Yoshimoto; Kenji Ashida; Yoshihiro Ogawa; Junji Kawashima; Masakatsu Sone; Nobuya Inagaki; Katsutoshi Takahashi; Minemori Watanabe; Yuichi Matsuda; Hiroki Kobayashi; Hirotaka Shibata; Kohei Kamemura; Michio Otsuki; Yuichi Fujii; Koichi Yamamto; Atsushi Ogo; Shintaro Okamura; Shozo Miyauchi; Tomikazu Fukuoka; Shoichiro Izawa; Toshihiko Yanase; Shigeatsu Hashimoto; Masanobu Yamada; Yuichiro Yoshikawa; Tatsuya Kai; Tomoko Suzuki; Takashi Kawamura; Mitsuhide Naruse
Journal:  J Endocr Soc       Date:  2018-05-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.